Position in JNJ
as of Jun 30, 2026
· filed Aug 17, 2026
Position Value
$3,145,164
+$1,120,957 QoQ
Shares Held
12,384
+49.5% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.26%
of 13F equity value
Holder Rank
#1,974
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026CENTAURUS FINANCIAL, INC. holds $28,490,833 across 13 Drug Manufacturers - General names. JNJ ranks #3 (11.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
12,081 | $14,490,315 | |
| 2 | ABBV |
AbbVie Inc.
|
13,295 | $3,345,553 | |
| 3 | JNJ |
Johnson & Johnson
This page
|
12,384 | $3,145,164 | |
| 4 | MRK |
Merck & Co., Inc.
|
11,912 | $1,530,692 | |
| 5 | AMGN |
Amgen Inc
|
3,413 | $1,235,915 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
7,694 | $972,059 | |
| 7 | NVS |
Novartis AG
|
5,748 | $900,826 | |
| 8 | PFE |
Pfizer Inc
|
36,772 | $885,469 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,145,164 | 12,384 | Shares | Sole | 2026-08-17 | |
| 2026-03-31 | $2,024,207 | 8,281 | Shares | Sole | 2026-05-18 | |
| 2025-12-31 | $1,750,383 | 8,458 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $1,539,913 | 8,305 | Shares | Sole | 2025-11-20 | |
| 2025-06-30 | $1,253,313 | 8,205 | Shares | Sole | 2025-08-29 | |
| 2025-03-31 | $1,357,234 | 8,184 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $1,184,437 | 8,190 | Shares | Sole | 2025-03-12 | |
| 2024-09-30 | $1,323,544 | 8,167 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $1,269,984 | 8,689 | Shares | Sole | 2024-09-23 | |
| 2024-03-31 | $1,562,126 | 9,875 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $1,742,478 | 11,117 | Shares | Sole | 2024-02-26 | |
| 2023-09-30 | $1,690,977 | 10,857 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $1,858,458 | 11,228 | Shares | Sole | 2023-08-15 | |
| 2023-03-31 | $2,287,335 | 14,757 | Shares | Sole | 2023-05-18 | |
| 2022-12-31 | $2,829,933 | 16,020 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $2,284,589 | 13,985 | Shares | Sole | 2022-12-05 | |
| 2022-06-30 | $2,609,752 | 14,702 | Shares | Sole | 2022-08-02 | |
| 2022-03-31 | $2,412,986 | 13,615 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $2,740,028 | 16,017 | Shares | Sole | 2022-02-01 | |
| 2021-09-30 | $2,448,824 | 15,163 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $2,324,810 | 14,112 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $2,031,694 | 12,362 | Shares | Sole | 2021-04-30 | |
| 2020-12-31 | $1,483,621 | 9,427 | Shares | Sole | 2021-01-25 | |
| 2020-09-30 | $1,786,411 | 11,999 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $1,180,729 | 8,396 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $881,062 | 6,719 | Shares | Sole | 2020-04-21 | |
| No filing history on record for this holder in this stock. | ||||||